Polatuzumab (Anti-CD79b) is a monoclonal antibody which targets CD79b that is found on the surface of B cells. The antibody-drug conjugate (ADC) Polatuzumab vedotin, marketed under the brand name Polivy, is a medicine used to treat diffuse large B-cell lymphoma (DLBCL), a type of non-Hodgkin lymphoma. This ADC drug is a conjugate that combines a monoclonal antibody Polatuzumab, linker and a chemotherapy drug monomethyl auristatin E (MMAE). This biosimilar antibody is used for research only. MW: 145.5 KD.
Product Details |
Species Reactivity | Human |
---|
Host/Isotype | Human IgG1 |
---|
Class | Monoclonal |
---|
Type | Recombinant Antibody |
---|
Immunogen | Human CD79b |
---|
Clone | Polatuzumab biosimilar |
---|
Conjugate | Unconjugated |
---|
Purity | 99% |
---|
Molecular Weight | 145.5 KD |
---|
Protein Concentration | 1mg/ml |
---|
Storage Condition | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
---|
Storage Buffer | 100mM Pro-Ac, 20mM Arg-Ac, pH 5.0 |